OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use
Alice T Epitropoulos,1,2 Sheraz M Daya,3 Cynthia Matossian,4 Alan G Kabat,5,6 Gretchen Blemker,5 Kristen Striffler,5 Laura Hendrix,5 Marian Macsai,5 Andrea Gibson5 1Ophthalmic Surgeons & Consultants of Ohio, the Eye Center of Columbus, Columbus, OH, USA; 2Department of Ophthalmology, the Ohio St...
Main Authors: | Epitropoulos AT, Daya SM, Matossian C, Kabat AG, Blemker G, Striffler K, Hendrix L, Macsai M, Gibson A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-10-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/oc-01-varenicline-solution-nasal-spray-demonstrates-consistency-of-eff-peer-reviewed-fulltext-article-OPTH |
Similar Items
-
OC-01 (Varenicline Solution) Nasal Spray for the Treatment of Dry Eye Disease Signs and Symptoms in Subjects with Autoimmune Disease: Integrated Data from ONSET-1 and ONSET-2
by: Schallhorn JM, et al.
Published: (2023-03-01) -
Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation
by: S. R. Gilyarevskiy
Published: (2019-03-01) -
Combination of behavioral therapy and varenicline for smoking cessation: Time to beat nicotine
by: Avnica Agarwal, et al.
Published: (2022-01-01) -
Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis
by: Saeed Ahmed, et al.
Published: (2018-09-01) -
Tobacco smoking cessation management: integrating varenicline in current practice
by: Laurence M Galanti
Published: (2008-08-01)